The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.
ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.
Congress introdues legislation to protect FDA user fees from sequestration.
The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo.
The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration.
The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.
The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change.
Lupin will bring to market a generic version of Lumigan solution, the company announced.
NPA renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.